株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

IVD (体外診断) の米国市場予測:市場規模・シェア・主な契約・企業分析

United States IVD Market (By Application Segments, Products, Region, End Users) Size, Share, Major Deals & Company Analysis - Forecast to 2025

発行 iGate Research Pvt Ltd 商品コード 911159
出版日 ページ情報 英文 201 Pages
即納可能
価格
本日の銀行送金レート: 1USD=109.55円で換算しております。
Back to Top
IVD (体外診断) の米国市場予測:市場規模・シェア・主な契約・企業分析 United States IVD Market (By Application Segments, Products, Region, End Users) Size, Share, Major Deals & Company Analysis - Forecast to 2025
出版日: 2019年09月17日 ページ情報: 英文 201 Pages
概要

当レポートパッケージでは、薬剤標的としてのRNAに対する低分子の創薬・開発環境について分析しており、低分子を用いてRNAを標的にするアプローチ、市場におけるステークホルダー、RNAバイオロジーの技術と低分子創薬、主なRNA標的低分子を用いた前臨床・臨床経験、融資状況、および主要企業のプロファイルなどをまとめています。

第1章 エグゼクティブサマリー

第2章 米国:体外診断市場・予測

第3章 米国:体外診断市場のシェア・予測

  • アプリケーション区分別
  • 製品別
  • 地域別
  • エンドユーザー別

第4章 アプリケーション区分別:米国のIVD診断市場・予測

  • 臨床化学
  • 微生物学:ID/AST
  • 微生物学:分子
  • POC:専門向け
  • POC:OTC糖尿病
  • POC:その他
  • 免疫測定法:感染症
  • 免疫測定法:その他
  • 尿検査
  • 凝固:感染症以外
  • 組織学
  • 血液学
  • 血液検査・血液型判定
  • フローケミストリー

第5章 製品別

  • IVD装置
  • IVD試薬
  • IVDサービス
  • IVDソフトウェア

第6章 地域別

  • 南部
  • 西部
  • 中西部
  • 北部

第7章 エンドユーザー別

  • 病院
  • ラボ
  • その他

第8章 企業プロファイル

  • Roche Diagnostics
  • Abbott Diagnostics
  • Siemens Healthineers
  • Danaher Corporation
  • Thermo Fisher Scientific
  • Sysmex Corporation
  • Biomerieux
  • Bio-Rad Laboratories, Inc
  • Becton Dickinson and Company

第9章 主な契約

第10章 成長の促進要因

第11章 課題

目次

United States In Vitro Diagnostics (IVD) market is expected to reach US$ 33.7 Billion by 2025. United States represents the largest IVD market across the world. With an aging population, technological advances and advent of point of care diagnostics, United States IVD market is slated to show substantial growth in the future. The increase in the US in vitro diagnostics market is majorly driven by high prevalence of chronic diseases, such as heart diseases, cancer, asthma, and diabetes. It is estimated that these diseases are responsible for the majority of deaths in the United States, killing more than 1.7 million US citizens annually. All of these conditions can be diagnosed and monitored using IVD products. Thus, IVDs have proved to be beneficial in managing these chronic conditions. However, some of the factors limiting the growth of the market are a lack of proper reimbursement policies and lack of skilled lab technicians.

Application Segments Analysis

  • On the basis of segment, the POC-OTC diabetes diagnostics segment accounted for highest share of the United States in-vitro diagnostics market, followed by the POC - Professional segment.
  • Immunoassays have become one of the primary and indispensable tools in the diagnosis and monitoring of all diseases and medical conditions.
  • The non-infectious immunoassays contribute significantly to the United States IVD market.
  • It is anticipated that the molecular microbiology segment will account for nearly 10% share of the United States IVD market by 2025.
  • The Clinical chemistry segment contributed around 8% to the United States IVD market in 2018.
  • Histology and Hematology segments are competing closely with each other to grab maximum share of the pie.
  • Urinalysis captures least share of the United States in vitro diagnostics market.

Products Analysis

  • Instruments is the leading product segment of the United States In-Vitro Diagnostics (IVD) market, followed by the reagents segment.
  • The software segment holds close to 15% share of the United States IVD market in 2018, due to growing preference for reliable and efficient diagnostic software.
  • Services segment captured least share of the United States in vitro diagnostics market, but it is likely to show impressive growth throughout the forecast period.

Regional Analysis

  • The largest share of the US in vitro diagnostics market is currently in the South of the country with the West being second.
  • Midwest region accounts for nearly 22% share of the total US IVD market in 2018, as an increasing number of accredited laboratories opening in that area.
  • The North East region accounted for least share of the total US IVD market.

End Users Analysis

  • Hospitals captures highest share of the United States IVD market, owing to the large volume of diagnostic tests carried out in hospitals.
  • An increasing number of independent accredited laboratories are opening all over the country, thus driving the market for laboratories segment.
  • The other end users (Self Testing, Retail Clinics, Physician Office Labs, Others) segment contributed nearly a quarter to the United States IVD market.

iGATE RESEARCH report titled "United States IVD Market (By Application Segments, Products, Region, End Users) Size, Share, Major Deals & Company Analysis - Forecast to 2025" provides a comprehensive assessment of the fast-evolving, high-growth United States IVD Market.

This 201 Page report with 73 Figures and 8 Tables has been analyzed from 9 View Points:

1) United States IVD Market and Forecast (2013 - 2025)

2) United States IVD Market Share and Forecast (2013 - 2025)

3) United States IVD Market & Forecast - By Application Segments (2013 - 2025)

4) United States IVD Market & Forecast - By Products (2013 - 2025)

5) United States IVD Market & Forecast - By Region (2013 - 2025)

6) United States IVD Market & Forecast - By End Users (2013 - 2025)

7) United States IVD Market & Forecast - Company Profiles (2013 - 2025)

8) United States IVD Market - Major Deals

9) United States IVD Industry Drivers & Challenges

By Application Segments

1. Clinical Chemistry

2. Microbiology -ID/AST

3. Microbiology - Molecular

4. POC - Professional

5. POC - OTC Diabetes

6. POC - Others

7. Immunoassay - Infectious

8. Immunoassay - Others

9. Urinalysis

10. Molecular - Non-Infectious

11. Coagulation

12. Histology

13. Hematology

14. Blood Testing and Typing

15. Flow Cytometry

By Products

  • Instruments
  • Reagents
  • Software
  • Services

By Region

  • South
  • West
  • Midwest
  • North East

By End Users

  • Hospitals
  • Laboratories
  • Others

Company Profiles

1. Roche Diagnostic

2. Abbott Laboratories

3. Siemens Healthineers

4. Danaher Corporation

5. Thermo Fisher Scientific

6. Sysmex Corporation

7. Biomerieux

8. Bio-Rad Laboratories, Inc

9. Becton Dickinson and Company

Data Source

iGATE RESEARCH employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by iGATE Research dedicated team of qualified professionals with deep industry experience and expertise.

Research Methodologies

Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.

Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.

Table of Contents

1. Executive Summary

2. United States - In-Vitro Diagnostics Market and Forecast (2013 - 2025)

3. United States - In-Vitro Diagnostics Market Share and Forecast (2013 - 2025)

  • 3.1 By Application Segments - United States In-Vitro Diagnostics Market Share and Forecast
  • 3.2 By Products - United States In-Vitro Diagnostics Market Share and Forecast
  • 3.3 By Region - United States In-Vitro Diagnostics Market Share and Forecast
  • 3.4 By End Users - United States In-Vitro Diagnostics Market Share and Forecast

4. By Application Segments - United States In-Vitro Diagnostics Market and Forecast (2013 - 2025)

  • 4.1 United States - Clinical Chemistry Market and Forecast
  • 4.2 United States - Microbiology -ID/AST Market and Forecast
  • 4.3 United States - Microbiology - Molecular Market and Forecast
  • 4.4 United States - POC - Professional Market and Forecast
  • 4.5 United States - POC - OTC Diabetes Market and Forecast
  • 4.6 United States - POC - Others Market and Forecast
  • 4.7 United States - Immunoassay - Infectious Market and Forecast
  • 4.8 United States - Immunoassay - Others Market and Forecast
  • 4.9 United States - Urinalysis Market and Forecast
  • 4.10 United States - Molecular - Non-Infectious Market and Forecast
  • 4.11 United States - Coagulation Market and Forecast
  • 4.12 United States - Histology Market and Forecast
  • 4.13 United States - Hematology Market and Forecast
  • 4.14 United States - Blood Testing and Typing Market and Forecast
  • 4.15 United States - Flow Cytometry Market and Forecast

5. By Products - United States In-Vitro Diagnostics Market and Forecast (2013 - 2025)

  • 5.1 United States - In-Vitro Diagnostics Instruments Market and Forecast
  • 5.2 United States - In-Vitro Diagnostics Reagents Market and Forecast
  • 5.3 United States - In-Vitro Diagnostics Services Market and Forecast
  • 5.4 United States - In-Vitro Diagnostics Software Market and Forecast

6. By Region - United States In-Vitro Diagnostics Market and Forecast (2013 - 2025)

  • 6.1 South - In-Vitro Diagnostics Market and Forecast
  • 6.2 West - In-Vitro Diagnostics Market and Forecast
  • 6.3 Midwest - In-Vitro Diagnostics Market and Forecast
  • 6.4 North East - In-Vitro Diagnostics Market and Forecast

7. By End User - United States In-Vitro Diagnostics Market and Forecast (2013 - 2025)

  • 7.1 United States - Hospital In-Vitro Diagnostics Market and Forecast
  • 7.2 United States - Laboratories In-Vitro Diagnostics Market and Forecast
  • 7.3 United States - Others In-Vitro Diagnostics Market and Forecast

8. United States In-Vitro Diagnostics Market - Company Profiles

  • 8.1 Roche Diagnostics
    • 8.1.1 Company Overview
    • 8.1.2 Recent Developments
    • 8.1.3 Sales and Forecast
  • 8.2 Abbott Diagnostics
    • 8.2.1 Company Overview
    • 8.2.2 Recent Developments
    • 8.2.3 Sales and Forecast
  • 8.3 Siemens Healthineers
    • 8.3.1 Company Overview
    • 8.3.2 Recent Developments
    • 8.3.3 Sales and Forecast
  • 8.4 Danaher Corporation
    • 8.4.1 Company Overview
    • 8.4.2 Recent Developments
    • 8.4.3 Sales and Forecast
  • 8.5 Thermo Fisher Scientific
    • 8.5.1 Company Overview
    • 8.5.2 Recent Developments
    • 8.5.3 Sales and Forecast
  • 8.6 Sysmex Corporation
    • 8.6.1 Company Overview
    • 8.6.2 Recent Developments
    • 8.6.3 Sales and Forecast
  • 8.7 Biomerieux
    • 8.7.1 Company Overview
    • 8.7.2 Recent Developments
    • 8.7.3 Sales and Forecast
  • 8.8 Bio-Rad Laboratories, Inc
    • 8.8.1 Company Overview
    • 8.8.2 Recent Developments
    • 8.8.3 Sales and Forecast
  • 8.9 Becton Dickinson and Company
    • 8.9.1 Company Overview
    • 8.9.2 Recent Developments
    • 8.9.3 Sales and Forecast

9. United States IVD Market - Major Deals

  • 9.1 2019
  • 9.2 2018
  • 9.3 2017
  • 9.4 2016

10. United States In-Vitro Diagnostics Market - Growth Drivers

  • 10.1 High Prevalence of Chronic and Infectious Diseases
  • 10.2 Increase in geriatric population
  • 10.3 Technology Advancement Spurring the IVD Market
  • 10.4 Increasing Adoption of Automated Instruments and Automation in Laboratories Drives United States IVD Market

11. United States In-Vitro Diagnostics Market - Challenges

  • 11.1 Cumbersome Reimbursement Procedure
  • 11.2 Shortage of Lab Technicians

List of Figures:

  • Figure 2-1: United States - In-vitro Diagnostics Market (Million US$), 2013 - 2018
  • Figure 2-2: United States - Forecast for In-vitro Diagnostics Market (Million US$), 2019 - 2025
  • Figure 4-1: United States In-vitro Diagnostics - Clinical Chemistry Market (Million US$), 2013 - 2018
  • Figure 4-2: United States In-vitro Diagnostics - Forecast for Clinical Chemistry Market (Million US$), 2019 - 2025
  • Figure 4-3: United States In-vitro Diagnostics - Microbiology -ID/AST Market (Million US$), 2013 - 2018
  • Figure 4-4: United States In-vitro Diagnostics - Forecast for Microbiology -ID/AST Market (Million US$), 2019 - 2025
  • Figure 4-5: United States In-vitro Diagnostics - Microbiology - Molecular Market (Million US$), 2013 - 2018
  • Figure 4-6: United States In-vitro Diagnostics - Forecast for Microbiology - Molecular Market (Million US$), 2019 - 2025
  • Figure 4-7: United States In-vitro Diagnostics - POC - Professional Market (Million US$), 2013 - 2018
  • Figure 4-8: United States In-vitro Diagnostics - Forecast for POC - Professional Market (Million US$), 2019 - 2025
  • Figure 4-9: United States In-vitro Diagnostics - POC - OTC Diabetes Market (Million US$), 2013 - 2018
  • Figure 4-10: United States In-vitro Diagnostics - Forecast for POC - OTC Diabetes Market (Million US$), 2019 - 2025
  • Figure 4-11: United States In-vitro Diagnostics - POC - Others Market (Million US$), 2013 - 2018
  • Figure 4-12: United States In-vitro Diagnostics - Forecast for POC - Others Market (Million US$), 2019 - 2025
  • Figure 4-13: United States In-vitro Diagnostics - Immunoassay - Infectious Market (Million US$), 2013 - 2018
  • Figure 4-14: United States In-vitro Diagnostics - Forecast for Immunoassay - Infectious Market (Million US$), 2019 - 2025
  • Figure 4-15: United States In-vitro Diagnostics - Immunoassay - Others Market (Million US$), 2013 - 2018
  • Figure 4-16: United States In-vitro Diagnostics - Forecast for Immunoassay - Others Market (Million US$), 2019 - 2025
  • Figure 4-17: United States In-vitro Diagnostics - Urinalysis Market (Million US$), 2013 - 2018
  • Figure 4-18: United States In-vitro Diagnostics - Forecast for Urinalysis Market (Million US$), 2019 - 2025
  • Figure 4-19: United States In-vitro Diagnostics - Molecular - Non-Infectious Market (Million US$), 2013 - 2018
  • Figure 4-20: United States In-vitro Diagnostics - Forecast for Molecular - Non-Infectious Market (Million US$), 2019 - 2025
  • Figure 4-21: United States In-vitro Diagnostics - Coagulation Market (Million US$), 2013 - 2018
  • Figure 4-22: United States In-vitro Diagnostics - Forecast for Coagulation Market (Million US$), 2019 - 2025
  • Figure 4-23: United States In-vitro Diagnostics - Histology Market (Million US$), 2013 - 2018
  • Figure 4-24: United States In-vitro Diagnostics - Forecast for Histology Market (Million US$), 2019 - 2025
  • Figure 4-25: United States In-vitro Diagnostics - Hematology Market (Million US$), 2013 - 2018
  • Figure 4-26: United States In-vitro Diagnostics - Forecast for Hematology Market (Million US$), 2019 - 2025
  • Figure 4-27: United States In-vitro Diagnostics - Blood Testing and Typing Market (Million US$), 2013 - 2018
  • Figure 4-28: United States In-vitro Diagnostics - Forecast for Blood Testing and Typing Market (Million US$), 2019 - 2025
  • Figure 4-29: United States In-vitro Diagnostics - Flow Cytometry Market (Million US$), 2013 - 2018
  • Figure 4-30: United States In-vitro Diagnostics - Forecast for Flow Cytometry Market (Million US$), 2019 - 2025
  • Figure 5-1: United States In-vitro Diagnostics - Instruments Market (Million US$), 2013 - 2018
  • Figure 5-2: United States In-vitro Diagnostics - Forecast for Instruments Market (Million US$), 2019 - 2025
  • Figure 5-3: United States In-vitro Diagnostics - Reagents Market (Million US$), 2013 - 2018
  • Figure 5-4: United States In-vitro Diagnostics - Forecast for Reagents Market (Million US$), 2019 - 2025
  • Figure 5-5: United States In-vitro Diagnostics - Services Market (Million US$), 2013 - 2018
  • Figure 5-6: United States In-vitro Diagnostics - Forecast for Services Market (Million US$), 2019 - 2025
  • Figure 5-7: United States In-vitro Diagnostics - Software Market (Million US$), 2013 - 2018
  • Figure 5-8: United States In-vitro Diagnostics - Forecast for Software Market (Million US$), 2019 - 2025
  • Figure 6-1: United States In-vitro Diagnostics - South Region Market (Million US$), 2013 - 2018
  • Figure 6-2: United States In-vitro Diagnostics - Forecast for South Region Market (Million US$), 2019 - 2025
  • Figure 6-3: United States In-vitro Diagnostics - West Region Market (Million US$), 2013 - 2018
  • Figure 6-4: United States In-vitro Diagnostics - Forecast for West Region Market (Million US$), 2019 - 2025
  • Figure 6-5: United States In-vitro Diagnostics - Midwest Region Market (Million US$), 2013 - 2018
  • Figure 6-6: United States In-vitro Diagnostics - Forecast for Midwest Region Market (Million US$), 2019 - 2025
  • Figure 6-7: United States In-vitro Diagnostics - North East Region Market (Million US$), 2013 - 2018
  • Figure 6-8: United States In-vitro Diagnostics - Forecast for North East Region Market (Million US$), 2019 - 2025
  • Figure 7-1: United States In-vitro Diagnostics - Hospital Market (Million US$), 2013 - 2018
  • Figure 7-2: United States In-vitro Diagnostics - Forecast for Hospital Market (Million US$), 2019 - 2025
  • Figure 7-3: United States In-vitro Diagnostics - Laboratories Market (Million US$), 2013 - 2018
  • Figure 7-4: United States In-vitro Diagnostics - Forecast for Laboratories Market (Million US$), 2019 - 2025
  • Figure 7-5: United States In-vitro Diagnostics - Others Market (Million US$), 2013 - 2018
  • Figure 7-6: United States In-vitro Diagnostics - Forecast for Others Market (Million US$), 2019 - 2025
  • Figure 8-1: Roche Diagnostics - Global Sales (Million US$), 2013 - 2018
  • Figure 8-2: Roche Diagnostics - Forecast for Global Sales (Million US$), 2019 - 2025
  • Figure 8-3: Abbott Laboratories - Global Diagnostics Sales (Million US$), 2013 - 2018
  • Figure 8-4: Abbott Laboratories - Forecast for Global Diagnostics Sales (Million US$), 2019 - 2025
  • Figure 8-5: Siemens Healthineers - Global Diagnostics Sales (Million US$), 2013 - 2018
  • Figure 8-6: Siemens Healthineers - Forecast for Global Diagnostics Sales (Million US$), 2019 - 2025
  • Figure 8-7: Danaher Corporation - Global Diagnostics Sales (Million US$), 2014 - 2018
  • Figure 8-8: Danaher Corporation - Forecast for Global Diagnostics Sales (Million US$), 2019 - 2025
  • Figure 8-9: Thermo Fisher Scientific - Global Diagnostics Sales (Million US$), 2013 - 2018
  • Figure 8-10: Thermo Fisher Scientific - Forecast for Global Diagnostics Sales (Million US$), 2019 - 2025
  • Figure 8-11: Sysmex Corporation - Global Diagnostics Sales (Million US$), 2014 - 2018
  • Figure 8-12: Sysmex Corporation - Forecast for Global Diagnostics Sales (Million US$), 2019 - 2025
  • Figure 8-13: bioMerieux - Global Diagnostics Sales (Million US$), 2015 - 2018
  • Figure 8-14: bioMerieux - Forecast for Global Diagnostics Sales (Million US$), 2019 - 2025
  • Figure 8-15: Bio-Rad Laboratories, Inc. - Global Diagnostics Sales (Million US$), 2014 - 2018
  • Figure 8-16: Bio-Rad Laboratories, Inc. - Forecast for Global Diagnostics Sales (Million US$), 2019 - 2025
  • Figure 8-17: Becton, Dickinson and Company - Global Diagnostics Sales (Million US$), 2014 - 2018
  • Figure 8-18: Becton, Dickinson and Company - Forecast for Global Diagnostics Sales (Million US$), 2019 - 2025
  • Figure 10-1: United States - Geriatric Population and Forecast (Million), 2016, 2018, 2060

List of Tables:

  • Table 3-1: By Application Segments - United States In-Vitro Diagnostics Market Share (Percent), 2013 - 2018
  • Table 3-2: By Application Segments - Forecast for United States In-Vitro Diagnostics Market Share (Percent), 2019 - 2025
  • Table 3-3: By Products - United States In-Vitro Diagnostics Market Share (Percent), 2013 - 2018
  • Table 3-4: By Products - Forecast for United States In-Vitro Diagnostics Market Share (Percent), 2019 - 2025
  • Table 3-5: By Region- United States In-Vitro Diagnostics Market Share (Percent), 2013 - 2018
  • Table 3-6: By Region- Forecast for United States In-Vitro Diagnostics Market Share (Percent), 2019 - 2025
  • Table 3-7: By End Users - United States In-Vitro Diagnostics Market Share (Percent), 2013 - 2018
  • Table 3-8: By End Users - Forecast for United States In-Vitro Diagnostics Market Share (Percent), 2019 - 2025
Back to Top